Maersk announced on Thursday the signing of a logistics agreement with Novo Nordisk effective from 2021.
The three-year agreement on cold chain logistics covers transportation, including maritime services and inland logistics.
“We are proud to have been chosen as one of Novo Nordisk’s premier logistics companies. Transporting pharmaceuticals globally is a demanding task with various complexities that require flexible and resilient supply chains as well as digital and green solutions.” said Vincent Clerc, executive vice president and CEO of the shipping company’s Ocean and Logistics.
One of the world’s largest pharmaceutical companies, Novo Nordisk has chosen Maersk’s ECO Delivery to reduce its carbon footprint in transportation.
The initiative uses sustainable biofuel to power selected vessels and helps Novo Nordisk advance towards its ambitious sustainability goals.
The global agreement will enter into force as of April 1, 2021.
“Our ambition to achieve zero environmental impact is a cornerstone of our aspiration to be a truly sustainable business,” said Runa Sylow, corporate vice president of strategic sourcing, Novo Nordisk.
The shipping line operates in 130 countries and employs approximately 80,000 people.